Filing Details
- Accession Number:
- 0001144204-11-032494
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-25 22:25:10
- Reporting Period:
- 2011-05-17
- Filing Date:
- 2011-05-25
- Accepted Time:
- 2011-05-25 21:25:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1326190 | Pharmathene Inc | PIP | Pharmaceutical Preparations (2834) | 202726770 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1409487 | D Valerie Riddle | C/O Pharmathene, Inc. One Park Place, Suite 450 Annapolis MD 21401 | Svp, Medical Director | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.0001 Par Value Per Share | Acquisiton | 2011-05-23 | 3,438 | $2.46 | 56,761 | No | 4 | M | Direct | |
Common Stock, $0.0001 Par Value Per Share | Disposition | 2011-05-23 | 3,438 | $3.68 | 53,323 | No | 4 | S | Direct | |
Common Stock, $0.0001 Par Value Per Share | Disposition | 2011-05-23 | 5,353 | $3.63 | 49,790 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option to purchase | Disposition | 2011-05-23 | 3,438 | $0.00 | 3,438 | $2.46 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
24,065 | 2019-01-21 | No | 4 | M | Direct |
Footnotes
- The transactions reported hereon have been effected pursuant to the Reporting Person's 10b5-1 Plan.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.628 to $3.633, inclusive.
- The option exercised is part of a January 21, 2009 grant of options to purchase an aggregate of 27,503 shares, which vests over a 4 year period with 25% each vesting on the first, second, third and fourth anniversaries of the grant date.